<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Multiple approaches have been investigated with the ultimate goal of providing insulin independence to patients with either type 1 or type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Approaches to produce insulin-secreting cells in culture, convert non-β-cells into functional β-cells or engineer autologous cells to express and secrete insulin in a meal-responsive manner have <z:hpo ids='HP_0000001'>all</z:hpo> been described </plain></SENT>
<SENT sid="2" pm="."><plain>This research has been facilitated by significant improvements in both <z:mp ids='MP_0001799'>viral</z:mp> and non-<z:mp ids='MP_0001799'>viral</z:mp> gene delivery approaches that have enabled new experimental strategies </plain></SENT>
<SENT sid="3" pm="."><plain>Many studies have examined possible avenues to confer islet cytoprotection against immune rejection, <z:mp ids='MP_0001845'>inflammation</z:mp> and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> by genetic manipulation of islet cells prior to islet transplantation </plain></SENT>
<SENT sid="4" pm="."><plain>Here we review several reports based on the reprogramming of pancreas and gut <z:chebi fb="32" ids="24621">endocrine</z:chebi> cells to treat <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>